Dr. George is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
44 Binney St
# Dana
Boston, MA 02115Phone+1 617-632-5204Fax+1 617-632-3408
Education & Training
- Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1998 - 2001
- Tufts Medical CenterResidency, Internal Medicine, 1997 - 1998
- University of North Carolina HospitalsResidency, Internal Medicine, 1995 - 1997
- University of Massachusetts Medical SchoolClass of 1995
Certifications & Licensure
- NH State Medical License 2004 - Present
- MA State Medical License 1999 - 2026
- NC State Medical License 1996 - 1998
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2013-2014
- America's Top Doctors for Cancer Castle Connolly, 2012-2013
Clinical Trials
- Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas Start of enrollment: 2003 Feb 01
- Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma Start of enrollment: 2009 Feb 01
- RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms Start of enrollment: 2009 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 143 citationsRetrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma.Suzanne George, Constance M. Barysauskas, César Serrano, Titilope Oduyebo, Jose Alejandro Rauh-Hain
Cancer. 2014-10-15 - 108 citationsUltra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entitiesSilvia Stacchiotti, Anna Maria Frezza, Jean-Yves Blay, Elizabeth H. Baldini, Sylvie Bonvalot
Cancer. 2021-08-15 - 12 citationsA phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.Steven Attia, Vanessa Bolejack, Kristen N Ganjoo, Suzanne George, Mark Agulnik
Cancer Medicine. 2023-01-01
Journal Articles
- Translational Insights into Gastrointestinal Stromal Tumor and Current Clinical AdvancesM C Heinrich, S George, M L Hemming, Annals of Oncology
Lectures
- Mutation profile of drug resistant gastrointestinal stromal tumor (GIST) patients (pts) enrolled in the phase 1 study of DCC-2618.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Other
- Surgical treatment and other localized therapy for metastatic soft tissue sarcomaGeorge S, Raut CP, Demetri GD
http://www.uptodate.com/contents/surgical-treatment-and-other-localized-therapy-for-metastatic-soft-
UpToDate, Wolters Kluwer Health - 2012-07-03 - Systemic treatment of metastatic soft tissue sarcomaGeorge S, Demetri GD
http://www.uptodate.com/contents/systemic-treatment-of-metastatic-soft-tissue-sarcoma
UpToDate, Wolters Kluwer Health - 2013-03-18
Press Mentions
- Chemo-ICI Combo Promising in Soft Tissue SarcomaNovember 14th, 2021
- The Life Raft Group, a Non-Profit Supporting Patients with GIST Cancer, Announces Members of the 2021 Medical Advisory BoardMarch 16th, 2021
- Blueprint Medicines Wins FDA Approval for Its First DrugJanuary 9th, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: